Zevra Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.16M-1.60M-2.67M-5.51M-5.78M-5.47M12.84M13.29M28.65M10.16M27.46M23.61M
Cost of Revenue 2.06M0.22M2.17M7.42M
Gross Profit -0.16M-1.60M-2.67M-5.51M-5.78M-5.47M12.84M13.29M26.59M9.94M25.29M16.20M
Operating items
Amortization - Intangibles 0.77M6.24M
Research & Development 3.37M11.92M13.93M20.47M20.59M41.76M19.41M8.84M10.16M19.80M39.81M42.09M
Selling, General & Administrative 1.35M4.53M8.88M14.00M12.77M12.51M10.82M7.92M8.70M15.04M34.31M54.87M
Other Operating Expenses 3.01M1.64M2.94M2.13M2.06M-80.65M-78.88M
Operating Expenses 4.72M16.44M22.81M37.48M33.37M55.90M33.18M18.90M20.92M52.73M74.12M96.96M
Operating Income -4.72M-16.44M-22.81M-37.48M-33.37M-55.90M-20.34M-5.61M7.73M-42.56M-49.60M-87.00M
EBIT -4.72M-16.44M-22.81M-37.48M-33.37M-55.90M-20.34M-5.61M7.73M-42.56M-49.60M-87.00M
Non-operating items
Non Operating Investment Income -0.01M-0.58M
Interest & Investment Income 0.05M0.01M0.03M0.35M0.36M0.42M0.31M0.09M0.26M1.51M4.54M2.17M
Other Non Operating Income 1.90M-4.74M0.00M-16.10M1.41M6.21M
Non Operating Income -0.53M-8.03M-31.82M20.95M-10.06M-0.69M-4.21M-7.18M-16.25M15.76M3.56M-3.14M
Net income details
EBT -5.25M-24.48M-54.64M-16.53M-43.43M-56.59M-24.54M-12.80M-8.52M-26.80M-46.05M-90.14M
Tax Provisions -0.02M0.02M0.03M-0.01M-0.04M-0.13M-0.02M-0.03M0.03M-0.03M15.37M
Profit After Tax -5.23M-24.45M-54.66M-16.52M-43.39M-56.47M-24.52M-12.76M-8.55M-26.77M-46.05M-105.51M
Income from Continuing Operations -5.23M-24.50M-54.66M-16.52M-43.39M-56.47M-24.52M-12.77M-8.55M-26.77M-46.05M-105.51M
Consolidated Net Income -5.23M-24.50M-54.66M-16.52M-43.39M-56.47M-24.52M-12.77M-8.55M-26.77M-46.05M-105.51M
Income towards Parent Company -5.23M-24.50M-54.66M-16.52M-43.39M-56.47M-24.52M-12.77M-8.55M-26.77M-46.05M-105.51M
Preferred Dividend Payments 54.34M
Net Income towards Common Stockholders -5.23M-24.50M-54.66M-16.52M-43.39M-56.47M-24.52M-12.76M-62.90M-41.54M-46.05M-105.51M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 0.77M0.90M0.92M0.92M1.65M2.08M4.53M35.32M34.50M36.22M53.38M
EBITDA -4.72M-16.44M-22.81M-37.48M-33.37M-55.90M-20.34M-5.61M7.73M-42.56M-49.60M-87.00M
Tax Rate 0.38%0.09%0.10%0.22%0.09%0.27%0.12%